# Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs

> **NCT00241540** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 808 (—)

## Conditions studied

- GERD

## Interventions

- **DRUG:** Esomeprazole

## Key facts

- **NCT ID:** NCT00241540
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** 2002-08
- **Final completion:** 2002-08
- **Target enrollment:** 808 (—)
- **Last updated:** 2011-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00241540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00241540, "Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00241540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*